Comparing Nivolumab vs Taxotere
| Nivolumab | Taxotere (docetaxel) |
|
|---|
| Nivolumab | Taxotere (docetaxel) |
|
|---|---|---|
|
Prescription only
Prescribed for Head and Neck Cancer, Esophageal Carcinoma, Colorectal Cancer, Gastric Cancer, Hepatocellular Carcinoma, Hodgkin's Lymphoma, Malignant Pleural Mesothelioma, Melanoma, Melanoma -... View more |
Prescription only
Prescribed for Prostate Cancer, Breast Cancer, Non Small Cell Lung Cancer, Breast Cancer - Metastatic, Gastric Cancer, Head and Neck Cancer. Taxotere may also be used for purposes not listed in this... View more |
Related suggestions Head and Neck Cancer
Gastric Cancer
|
| More about Nivolumab | More about Taxotere (docetaxel) | |
| Ratings & Reviews | ||
|
Nivolumab has an average rating of 6.0 out of 10 from a total of 144 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 39% reported a negative effect. |
Taxotere has an average rating of 5.2 out of 10 from a total of 11 ratings on Drugs.com. 36% of reviewers reported a positive effect, while 45% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Nivolumab side effects |
View all Taxotere side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
||
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
|
|
| Brand Names | ||
| Opdivo | Other docetaxel brands include: Beizray, Docivyx | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
640.8 hours |
11.1 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 605 drugs are known to interact with Nivolumab:
|
A total of 523 drugs are known to interact with Taxotere:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
| Disease Interactions | ||
| First Approval Date | ||
|
December 22, 2014 |
May 14, 1996 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.